This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2008 Dec 1;178(11):1098-9.

doi: 10.1164/rccm.200808-1315ED.

Antibiotic prophylaxis for chronic obstructive pulmonary disease: resurrecting an old idea

Ken M Kunisaki, Dennis E Niewoehner

PMID: 19023036
DOI: 10.1164/rccm.200808-1315ED

Editorial

Antibiotic prophylaxis for chronic obstructive pulmonary disease: resurrecting an old idea

Ken M Kunisaki et al. Am J Respir Crit Care Med. 2008.

. 2008 Dec 1;178(11):1098-9.

doi: 10.1164/rccm.200808-1315ED.

Authors

Ken M Kunisaki, Dennis E Niewoehner

PMID: 19023036
DOI: 10.1164/rccm.200808-1315ED

No abstract available

PubMed Disclaimer

Comment on

Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
Seemungal TA, Wilkinson TM, Hurst JR, Perera WR, Sapsford RJ, Wedzicha JA. Seemungal TA, et al. Am J Respir Crit Care Med. 2008 Dec 1;178(11):1139-47. doi: 10.1164/rccm.200801-145OC. Epub 2008 Aug 21. Am J Respir Crit Care Med. 2008. PMID: 18723437 Clinical Trial.

Similar articles

Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
Seemungal TA, Wilkinson TM, Hurst JR, Perera WR, Sapsford RJ, Wedzicha JA. Seemungal TA, et al. Am J Respir Crit Care Med. 2008 Dec 1;178(11):1139-47. doi: 10.1164/rccm.200801-145OC. Epub 2008 Aug 21. Am J Respir Crit Care Med. 2008. PMID: 18723437 Clinical Trial.
[Contribution to a debate on Cochrane analysis].
Frimodt-Møller N. Frimodt-Møller N. Ugeskr Laeger. 2007 Jun 11;169(24):2343. Ugeskr Laeger. 2007. PMID: 17607862 Danish. No abstract available.
Are prophylactic antibiotics useful in chronic obstructive pulmonary disease?
Arenas A, Rada G. Arenas A, et al. Medwave. 2015 Nov 10;15 Suppl 3:e6309. doi: 10.5867/medwave.2015.6309. Medwave. 2015. PMID: 26571418 English, Spanish.
Antibiotic prevention of acute exacerbations of COPD.
Wenzel RP, Fowler AA 3rd, Edmond MB. Wenzel RP, et al. N Engl J Med. 2012 Jul 26;367(4):340-7. doi: 10.1056/NEJMct1115170. N Engl J Med. 2012. PMID: 22830464 Review. No abstract available.
[Sparse effect of long-term treatment with macrolides in patients with chronic obstructive pulmonary disease].
Jersild Jespersen M, Mygind LH, Vestbo J, Sonne J. Jersild Jespersen M, et al. Ugeskr Laeger. 2013 Mar 4;175(10):648-51. Ugeskr Laeger. 2013. PMID: 23462037 Review. Danish.

See all similar articles

Cited by

Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Zarogoulidis P, et al. Eur J Clin Pharmacol. 2012 May;68(5):479-503. doi: 10.1007/s00228-011-1161-x. Epub 2011 Nov 22. Eur J Clin Pharmacol. 2012. PMID: 22105373 Review.
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations.
Pomares X, Montón C, Espasa M, Casabon J, Monsó E, Gallego M. Pomares X, et al. Int J Chron Obstruct Pulmon Dis. 2011;6:449-56. doi: 10.2147/COPD.S23655. Epub 2011 Sep 6. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 22003290 Free PMC article.
Influencing the decline of lung function in COPD: use of pharmacotherapy.
Gladysheva ES, Malhotra A, Owens RL. Gladysheva ES, et al. Int J Chron Obstruct Pulmon Dis. 2010 Jun 3;5:153-64. doi: 10.2147/copd.s4577. Int J Chron Obstruct Pulmon Dis. 2010. PMID: 20631815 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information